Suppr超能文献

胰腺导管腺癌中的微小RNA:新的诊断和治疗线索

MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues.

作者信息

Seux Mylene, Iovanna Juan, Dagorn Jean-Charles, Dusetti Nelson J

机构信息

INSERM, U624 Stress cellulaire, Aix-Marseille Université, Campus de Luminy, Marseille, France.

出版信息

Pancreatology. 2009;9(1-2):66-72. doi: 10.1159/000178876. Epub 2008 Dec 12.

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs 19-24 nucleotides in length that regulate gene expression of target genes by translational repression. They regulate crucial processes such as development, proliferation, apoptosis, stress response and differentiation. Recent reports support a role for miRNAs in the initiation and progression of human malignancies; in particular, aberrant expression of miRNAs can contribute to carcinogenesis by promoting the expression of proto-oncogenes or by inhibiting the expression of tumor suppressor genes. Large high-throughput studies in patients revealed that miRNA profiling allows classifying tumors with high accuracy and predicting their outcome. In this review, we summarize recent knowledge about miRNA expression in pancreatic ductal adenocarcinoma, their possible molecular implications, and finally, we discuss the possible repercussion of these findings in terms of diagnosis and treatment of this disease.

摘要

微小RNA(miRNA)是长度为19 - 24个核苷酸的小型非编码RNA,通过翻译抑制作用调控靶基因的基因表达。它们调控诸如发育、增殖、凋亡、应激反应和分化等关键过程。最近的报告支持miRNA在人类恶性肿瘤的发生和发展中发挥作用;特别是,miRNA的异常表达可通过促进原癌基因的表达或抑制肿瘤抑制基因的表达而导致癌变。对患者进行的大规模高通量研究表明,miRNA谱分析能够高精度地对肿瘤进行分类并预测其预后。在本综述中,我们总结了关于胰腺导管腺癌中miRNA表达的最新知识、它们可能的分子影响,最后,我们讨论了这些发现对该疾病诊断和治疗可能产生的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验